IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
32 hedge funds and large institutions have $24.8M invested in Impel Pharmaceuticals Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
-3
Holders Change %
-8.57%
% of All Funds
0.51%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
3
Increased
6
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
$0 |
| 2 |
Citadel Advisors
Miami,
Florida
|
$0 |
| 3 |
JGC
J. Goldman & Co
New York
|
$112K |
| 4 |
Jane Street
New York
|
$0 |
| 5 |
State Street
Boston,
Massachusetts
|
$35.3K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| $2.8K | -$199 | -142 | -7% |
|
27
UBS Group
Zurich,
Switzerland
| $1.83K | -$609 | -435 | -25% |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $1K | +$1K | +1,038 | New |
|
29
Osaic Holdings
Scottsdale,
Arizona
| $805 | – | – | – |
|
30
Wells Fargo
San Francisco,
California
| $99 | +$1 | +1 | +1% |
|
|
NC
31
NewSquare Capital
Newtown Square,
Pennsylvania
| $28 | – | – | – |
|
32
Bank of America
Charlotte,
North Carolina
| $2 | -$31 | -31 | -94% |
|
|
GGHC
33
Gilder Gagnon Howe & Co
New York
| – | -$535K | -142,631 | Closed |
|
|
34
Citadel Advisors
Miami,
Florida
| – | -$187K | -49,759 | Closed |
|
|
35
Jane Street
New York
| – | -$49.3K | -13,147 | Closed |
|
36
Citigroup
New York
| – | -$240 | -64 | Closed |
|
|
CS
37
Credit Suisse
Zurich,
Switzerland
| – | -$8 | -2 | Closed |
|